20-F/A: C21 Investments Inc. Files Amendment to Transition Report on Form 20-F/A

Sentiment:

Form 20-F/A Amendment 7 March 2025 12:19 AM

C21 Investments Inc. amends its transition report to explicitly identify columnar headings and footnote disclosures for the two months ended March 31, 2024.

Capital raiseOn May 6, 2024, the Company closed a non-brokered private placement in which the Company issued 4,000 convertible debenture units of the Company for aggregate gross proceeds of C$4,000,000.Each convertible debenture unit offered under the private placement is comprised of: (i) a convertible debenture of the Company secured against the Nevada operations of the Company in principal amount of C$1,000; and (ii) 1,000 common share purchase warrants, each of which is exercisable for one common share at a price of C$0.55 per share for a period of 30 months from the issuance date.The principal amount of the convertible debentures, together with any accrued and unpaid interest, will mature and become due and payable on the date that is 30 months from the issue date, subject to earlier conversion or repayment.The principal amount owing under the convertible debentures will accrue interest from the issue date at rate of 12% per annum, payable quarterly in cash.The principal amount may be converted into common shares at the option of the holder at any time prior to the maturity date at a price of C$0.45 per common share.

Summary

C21 Investments Inc. filed an amendment to its transition report on Form 20-F/A to clarify the financial statements for the two-month period ended March 31, 2024.
The amendment explicitly identifies columnar headings and footnote disclosures applicable to the transition period.
The company's auditor, Davidson & Company LLP, issued an opinion stating that the financial statements present fairly the company's financial position as of March 31, 2024, and January 31, 2024, and the results of its operations and cash flows for the two-month fiscal year ended March 31, 2024, and the year ended January 31, 2024, in conformity with U.S. GAAP.
As of March 31, 2024, the company had 120,047,814 common shares issued and outstanding.
For the two months ended March 31, 2024, the company reported revenue of $4,464,950 and a net loss of $74,404.
The company's change in financial year end from January 31 to March 31 was approved by the Canadian Securities Exchange in May 2024.
The company completed the acquisition of a South Reno dispensary on June 7, 2024, for $3,500,000.

Sentiment

Score: 5

Explanation: The document is primarily factual, reporting on an amendment to a financial report and providing financial results. The sentiment is neutral, with both positive (acquisition, positive cash flow) and negative (net loss, working capital deficit) aspects.

Positives

The company generated positive operating cash flows from continuing operations for both the two months ended March 31, 2024, and the year ended January 31, 2024.
The company completed the acquisition of a South Reno dispensary on June 7, 2024, expanding its retail footprint.

Negatives

The company reported a net loss of $74,404 for the two months ended March 31, 2024.
As at March 31, 2024, the Company had a working capital deficit of $6,908,835.

Risks

Cannabis remains a Schedule I controlled substance under U.S. federal law, creating a dichotomy between state and federal law.
A change in the U.S. federal government's enforcement policies on cannabis could impact the company's ability to continue as a going concern.
The company is engaged in an ongoing dispute with vendors over repayment of convertible promissory notes.
The company's ability to service its debt depends on sustaining the profitability of its operations and obtaining sufficient financing on acceptable terms.
The company is involved in various litigation matters arising in the ordinary course of its business.

Future Outlook

The company's first full financial year under the new schedule will cover the twelve months ended March 31, 2025.

Industry Context

The company operates in the cannabis industry, which faces regulatory challenges due to the conflict between state and federal laws in the U.S.

Legal Proceedings

The Company is involved in ongoing legal proceedings, including the Oregon Action and the British Columbia Action, related to the acquisition of Eco Firma Farms, LLC.
The Company has filed a motion for costs and attorney fees totaling $108,876 in the Oregon Action, with a hearing scheduled for July 29, 2024.
A settlement conference is set for October 22, 2024, and a twelve-person jury trial is scheduled for November 19, 2024, in the Oregon Action.
The British Columbia Action remains in the discovery stage, and the trial date was removed due to lack of prosecution by Plaintiffs.

Related Party Transactions

The company has lease liabilities due to a company controlled by the CEO amounting to $4,917,482 as of March 31, 2024.
The company made payments to the CEO or companies controlled by the CEO for leases, repayments of promissory notes, and remuneration.
On June 5, 2023, the company controlled by the CEO sold its interest in the Silver State Relief LLC (Sparks) property, and on August 19, 2023, sold its interest in the Silver State Relief LLC (Fernley) property; the Company continues to lease these facilities from third parties.

Stakeholder Impact

The company's financial performance and legal proceedings could impact shareholders.
The acquisition of the South Reno dispensary could benefit customers by expanding access to cannabis products.
The company's operations and financial stability could affect employees and suppliers.

Next Steps

The company has a hearing scheduled for July 29, 2024, regarding a motion for costs and attorney fees.
A settlement conference is set for October 22, 2024, and a twelve-person jury trial is scheduled for November 19, 2024, related to legal proceedings.

Key Dates

Date	Description
1987-01-15	C21 Investments Inc. was incorporated.
2018-06-13	The Company issued convertible promissory notes to the vendors that sold Eco Firma Farms, LLC ('EFF') to the Company.
2019-05-24	The Company acquired Swell Companies.
2021-01-20	The Court ruled in the Company's favor, awarding the Company and its subsidiaries $68,195 in attorney's fees, $1,252 in costs, and a statutory prevailing party fee of $640, through a supplemental judgment, entered on February 2, 2021.
2022-01-31	The Company made a strategic decision to cease operations in Oregon.
2024-03-31	End of the transition period for the change in financial year end.
2024-05-06	The Company closed a non-brokered private placement in which the Company issued 4,000 convertible debenture units of the Company for aggregate gross proceeds of C$4,000,000.
2024-05-13	The Company granted 5,425,000 stock options to certain officers, directors, and employees.
2024-06-07	The Company completed the acquisition of a 6,500 square-foot, purpose-built, operational retail cannabis dispensary located in South Reno, Nevada.
2025-03-06	Date of certifications by the CEO and CFO.

Keywords

financial statements, cannabis, C21 Investments, amendment, Form 20-F, operations, revenue, net loss, Nevada, Oregon

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.